Enanta Pharmaceuticals, Inc.: shareholders and insiders

ENTANASDAQHealthcare · Pharmaceutical Preparations

Price

$7.98

November 19, 2026Market cap $230M

What Ploutos Investor adds for Enanta Pharmaceuticals

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 15 fiscal years, from FY2011
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
  • The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Aug 10, 2026, from their own Form 4 filings.

1 Form 4s

Bought on the market

–

nobody

Sold on the market

$183.2K

7 people

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan0%
  • The rest100%
  • Dec 5, 2025Jay R. LulyPresident and CEO
    Kind
  • Dec 5, 2025Yat Sun OrChief Scientific Officer
    Kind
  • Dec 5, 2025Tara Lynn KiefferChief Product Strategy Officer
    Kind
  • Dec 5, 2025Brendan LuuChief Business Officer
    Kind
  • Dec 5, 2025Scott T. RottinghausChief Medical Officer
    Kind
  • Dec 5, 2025Harry R. Trout III
    Kind
  • Dec 5, 2025Kathleen S. Capps
    Kind
  • Dec 2, 2025Harry R. Trout III
    Kind
  • Dec 2, 2025Kathleen S. Capps
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Aug 10, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by ENTA's officers and directors from 2013 up to November 19, 2025, 13 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

6 Holders over 5%1 On a 13DOct 27, 2026 Latest filing
  • Janus Henderson Groupwith 1 more person
    Share of class12.1%
  • Farallon Capital Management, L.L.C.with 26 more persons
    Share of class8.30%
  • BlackRock, Inc.
    Share of class7.80%
  • Jay R. Luly, Ph.D.
    Share of class7.70%
  • BlackRock Portfolio Management LLC
    Share of class5.40%
  • Krensavage Asset Management, LLCwith 2 more persons
    Share of class5.10%
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Deep Track Capital, LP4.97%Aug 14, 202613G/A
  • The Vanguard Group0.00%Mar 26, 202613G/A
  • Integrated Core Strategies (US) LLC2.30%Jan 20, 202613G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Millennium Mgmt (Englander)
    In the quarter+20%
  • Renaissance Technologies
    In the quarter-15%
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+173%
  • D.E. Shaw
    In the quarter+68%
  • AQR Capital
    In the quarter-9.2%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 7.85% of its shares outstanding were held short, -11.3% since the report before.

Shares held short
2.27M
7.85%
Since the report before2.55M on Sep 30, 2026
-11.3%
8.6
264.3K
More days to cover thanof 4,578 US-listed companies with enough volume
86%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 1.34M
  • Nov 15, 2023: Shares held short 1.51M
  • Nov 30, 2023: Shares held short 1.47M
  • Dec 15, 2023: Shares held short 1.80M
  • Dec 29, 2023: Shares held short 1.55M
  • Jan 12, 2024: Shares held short 1.59M
  • Jan 31, 2024: Shares held short 1.84M
  • Feb 15, 2024: Shares held short 2.21M
  • Feb 29, 2024: Shares held short 2.09M
  • Mar 15, 2024: Shares held short 2.41M
  • Mar 28, 2024: Shares held short 2.74M
  • Apr 15, 2024: Shares held short 2.74M
  • Apr 30, 2024: Shares held short 2.78M
  • May 15, 2024: Shares held short 2.80M
  • May 31, 2024: Shares held short 2.76M
  • Jun 14, 2024: Shares held short 2.76M
  • Jun 28, 2024: Shares held short 3.01M
  • Jul 15, 2024: Shares held short 2.91M
  • Jul 31, 2024: Shares held short 2.80M
  • Aug 15, 2024: Shares held short 2.96M
  • Aug 30, 2024: Shares held short 2.91M
  • Sep 13, 2024: Shares held short 2.92M
  • Sep 30, 2024: Shares held short 2.99M
  • Oct 15, 2024: Shares held short 3.43M
  • Oct 31, 2024: Shares held short 3.44M
  • Nov 15, 2024: Shares held short 3.38M
  • Nov 29, 2024: Shares held short 3.23M
  • Dec 13, 2024: Shares held short 3.37M
  • Dec 31, 2024: Shares held short 3.35M
  • Jan 15, 2025: Shares held short 3.23M
  • Jan 31, 2025: Shares held short 3.36M
  • Feb 14, 2025: Shares held short 3.57M
  • Feb 28, 2025: Shares held short 2.60M
  • Mar 14, 2025: Shares held short 2.63M
  • Mar 31, 2025: Shares held short 2.67M
  • Apr 15, 2025: Shares held short 2.80M
  • Apr 30, 2025: Shares held short 2.96M
  • May 15, 2025: Shares held short 2.85M
  • May 30, 2025: Shares held short 2.72M
  • Jun 13, 2025: Shares held short 2.50M
  • Jun 30, 2025: Shares held short 2.42M
  • Jul 15, 2025: Shares held short 2.46M
  • Jul 31, 2025: Shares held short 2.73M
  • Aug 15, 2025: Shares held short 2.88M
  • Aug 29, 2025: Shares held short 2.83M
  • Sep 15, 2025: Shares held short 2.85M
  • Sep 30, 2025: Shares held short 3.35M
  • Oct 15, 2025: Shares held short 2.81M
  • Oct 31, 2025: Shares held short 2.73M
  • Nov 14, 2025: Shares held short 2.80M
  • Nov 28, 2025: Shares held short 2.48M
  • Dec 15, 2025: Shares held short 2.28M
  • Dec 31, 2025: Shares held short 2.08M
  • Jan 15, 2026: Shares held short 2.26M
  • Jan 30, 2026: Shares held short 2.26M
  • Feb 13, 2026: Shares held short 2.28M
  • Feb 27, 2026: Shares held short 2.19M
  • Mar 13, 2026: Shares held short 2.16M
  • Mar 31, 2026: Shares held short 2.13M
  • Apr 15, 2026: Shares held short 2.10M
  • Apr 30, 2026: Shares held short 2.16M
  • May 15, 2026: Shares held short 2.20M
  • May 29, 2026: Shares held short 2.27M
  • Jun 15, 2026: Shares held short 2.43M
  • Jun 30, 2026: Shares held short 2.58M
  • Jul 15, 2026: Shares held short 2.44M
  • Jul 31, 2026: Shares held short 2.59M
  • Aug 14, 2026: Shares held short 2.68M
  • Aug 31, 2026: Shares held short 2.62M
  • Sep 15, 2026: Shares held short 2.60M
  • Sep 30, 2026: Shares held short 2.55M
  • Oct 15, 2026: Shares held short 2.27M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading40.4% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 40.4% of the shares in the reported trades were short sales, against 47.0% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
40.4%
The 14 beforeOct 13, 2026 – Oct 30, 2026
47.0%
Change
-6.6 pts
Short sales a dayon average, of 151.6K shares
61.3K
More than atof 3,666 US-listed companies, same days
21%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 42.4%
  • Oct 14, 2026: Short sales 40.5%
  • Oct 15, 2026: Short sales 44.1%
  • Oct 16, 2026: Short sales 66.5%
  • Oct 19, 2026: Short sales 51.5%
  • Oct 20, 2026: Short sales 26.5%
  • Oct 21, 2026: Short sales 42.8%
  • Oct 22, 2026: Short sales 56.9%
  • Oct 23, 2026: Short sales 45.3%
  • Oct 26, 2026: Short sales 43.8%
  • Oct 27, 2026: Short sales 31.5%
  • Oct 28, 2026: Short sales 58.5%
  • Oct 29, 2026: Short sales 56.6%
  • Oct 30, 2026: Short sales 66.3%
  • Nov 2, 2026: Short sales 55.2%
  • Nov 3, 2026: Short sales 54.6%
  • Nov 4, 2026: Short sales 56%
  • Nov 5, 2026: Short sales 50.3%
  • Nov 6, 2026: Short sales 52.3%
  • Nov 9, 2026: Short sales 28.4%
  • Nov 10, 2026: Short sales 36.2%
  • Nov 11, 2026: Short sales 54%
  • Nov 12, 2026: Short sales 63.9%
  • Nov 13, 2026: Short sales 49.6%
  • Nov 16, 2026: Short sales 39.4%
  • Nov 17, 2026: Short sales 21.4%
  • Nov 18, 2026: Short sales 34.6%
  • Nov 19, 2026: Short sales 50.3%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

1.51M Insiders' shares5.24% Of the company
  • Jay R. LulyPresident and CEO
    Directly858.0K
  • Yat Sun OrChief Scientific Officer
    Directly371.4K
  • Paul J MellettChief Fin. & Admin Officer
    Directly91.7K
  • Nathaniel S. GardinerSr. VP & General Counsel
    Directly68.2K
  • Brendan LuuChief Business Officer
    Directly38.3K
  • Tara Lynn KiefferChief Product Strategy Officer
    Directly30.6K
  • Scott T. RottinghausChief Medical Officer
    Directly23.8K
  • Harry R. Trout IIISee Remarks
    Directly16.3K
  • Kathleen S. CappsSee Remarks
    Directly8,377
  • Terry VanceDirector
    Directly5,800

A lower bound: it counts only the 10 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

14 ETFs holding it0.09% The largest weight (IWC)
  • IWCiShares Micro-Cap ETF
    Weight in the fund0.09%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.03%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.01%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.01%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.01%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.01%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.01%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • ITOTiShares Core S&P Total U.S. Stock Market ETF
    Weight in the fund0.00%

14 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

122 Managers, Q2 2026$397M Value of their positions
  • Q3 2025: Managers 122
  • Q4 2025: Managers 132
  • Q1 2026: Managers 135
  • Q2 2026: Managers 122

Institutional investors by quarter

The fund managers holding ENTA, quarter by quarter, from Q2 2013 to Q2 2025, 49 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 122 managers held 27.25M shares, worth $397M. During the quarter 13 opened a position, 26 closed one, 45 added and 37 trimmed.

The largest holders, Q2 2026

  • Jupiter Topco
    In the quarter
  • BlackRock
    In the quarter+4.5%
  • Krensavage Asset Management
    In the quarter
  • Farallon Capital Management
    In the quarter-16%
  • Deep Track Capital
    In the quarter-26%
  • ADAR1 Capital Management
    In the quarter×26.2
  • Vanguard Capital Management
    In the quarter+2.9%
  • Spruce Street Capital
    In the quarter+17%
  • Acadian Asset Management
    In the quarter+23%
  • Vanguard Portfolio Management
    In the quarter+6.6%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Enanta Pharmaceuticals's filings show?

Who buys and sells is one part of Enanta Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ENTA's shareholders

Didn't find what you were looking for?

Ask us
Have ENTA's insiders bought or sold?

From Aug 10, 2026 to Aug 10, 2026 Enanta Pharmaceuticals's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold ENTA?

6 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $10M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.